Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodies

Transplant Proc. 2001 Feb-Mar;33(1-2):248-9. doi: 10.1016/s0041-1345(00)01998-9.

Authors

R D Molano¹, T Berney, A Pileggi, C Ricordi, L Burkly, D Rothstein, G Basadonna, L Inverardi

Affiliation

¹ Diabetes Research Institute, University of Miami, Miami, Florida, USA.

PMID: 11266802
DOI: 10.1016/s0041-1345(00)01998-9

No abstract available

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
CD40 Ligand / immunology*
Graft Survival / immunology*
Islets of Langerhans Transplantation / immunology*
Islets of Langerhans Transplantation / physiology
Leukocyte Common Antigens / immunology*
Mice
Mice, Inbred C57BL
Mice, Inbred NOD
Time Factors
Transplantation, Homologous

Substances

Antibodies, Monoclonal
CD40 Ligand
Leukocyte Common Antigens